Mar 26, 2026 / 12:00PM GMT
Presentation
Mar 26, 2026 / 12:00PM GMT
=====================
Corporate Participants
=====================
* Yuly Chen
Ascentage Pharma Group International - Senior Director of Investor Relations
* Dajun Yang
Ascentage Pharma Group International - Executive Chairman of the Board, Chief Executive Officer, Co-Founder
* Veet Misra
Ascentage Pharma Group International - Chief Financial Officer
* Zhichao Si
Ascentage Pharma Group International - Head of Commercial
=====================
Conference Call Participants
=====================
* Brian Cheng
JPMorgan Chase & Co - Analyst
* Biren Amin
Piper Sandler - Analyst
* Supawat Thongthip
Truist Securities - Analyst
* Jeet Mukherjee
BTIG LLC - Equity Analyst
* Matthew Biegler
Oppenheimer & Co Inc - Analyst
* Christopher Liu
Lucid Capital Markets LLC - Analyst
* Michael King
Rodman & Renshaw - Analyst
=====================
Operator<
Ascentage Pharma Group International
(OTCPK:ASPHF)
$
4.53
-0.17 (-3.51%)
Market Cap: 1.51 Bil
Enterprise Value: 1.44 Bil
PE Ratio: 0
PB Ratio: 7.96
GF Score: 71/100 Full Year 2025 Ascentage Pharma Group International Earnings Presentation Transcript
Mar 26, 2026 / 12:00PM GMT
Release Date Price:
$8.48
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot